Supplementary Fig. 1 . Overview of the antibodies used in this study. The Western signals obtained from all antibodies used throughout this study are shown individually on an uncropped blot. The gels were loaded either with 60µg of total protein from whole cell extracts derived from HeLa cells treated with non-targeting siRNA (IN) or with 10% of the elution fraction from the co-immunoprecipitation experiments performed with anti-eIF3b antibodies (E). The size markers are indicated. The specificity of each band (marked by an asterisk where needed) was determined by 1) its mobility at the expected position on the SDS-PAGE as predicted by its molecular weight, 2) the fact that it specifically co-immunoprecipitates with the rest of eIF3 (see our eIF3b and eIF3f Co-IP experiments here and in (1), and 3) the fact that it specifically co-sediments with PICs in sucrose gradients (1). For a list of the antibodies please see Table S2 . Supplementary Fig. 2 . Cells knocked down for individual eIF3 subunits are not apoptotic at the time of performing the experiments. All knock-downs were checked for the presence of cleaved PARP-1, an indicator of apoptosis, by Western blotting, 3 days after siRNA transfection. GAPDH was used as loading control. NT: cells treated with non-targeting siRNA; STS: cells treated with 1µM Staurosporine, an inducer of apoptosis, for 4h; DMSO: cells treated with DMSO, the dissolvent of Staurosporine. The level of expression of PARP-1 in the 3d KD appears to be reduced, which might indicate that PARP-1 is partially downregulated in the eIF3d knocked down cells; this effect was, however, not examined any further in this study. Table 1 . Dark grey bars indicate no significant change compared to NT control cells while light grey bars indicate a significant change at p ≤ 0.01 (one sample t-test). (F) Asterisks indicate a significant change at p ≤ 0.05; please also note the signals for eIF3h, f, m, and c show no significant differences within this group; however, they differ significantly when compared to the group containing eIF3d, e, k, and l, or to the group featuring eIF3a, b, g, and i (t-test, p ≤ 0.05). Table 2 . Dark grey bars indicate no significant change compared to NT control cells while light grey bars indicate a significant change at p ≤ 0.
. The octameric right leg subunits eIF3k and eIF3l impact their own expression and are dispensable for the integrity of the rest of eIF3, and the octameric right arm subunit eIF3e stabilizes binding of the right leg subunits (k, l) and eIF3d to the octamer, as well as the octamer attachment to the YLC. Quantification of experiments shown in Fig. 3 . Quantified signals were normalized to NT control cells and to GAPDH or the bait eIF3b for the total protein levels or the CoIP analysis. The average of at least four experiments is shown ±SD. The rectangle encloses all eIF3 subunits forming the PCI/MPN octamer. eIF3 subunits comprising the yeast-like core (YLC) are highlighted in bold. A list of all values can be found in Table 1 . Dark grey bars indicate no significant change compared to NT control cells while light grey bars indicate a significant change at p ≤ 0.01 (one sample t-test). (F) Asterisks indicate a significant change at p ≤ 0.05; please also note the signals for eIF3h, f, m, and c show no significant differences within this group; however, they differ significantly when compared to the group containing eIF3d, e, k, and l, or to the group featuring eIF3a, b, g, and i (t-test, p ≤ 0.05). Supplementary Fig. 5 . Evidence of specificity of the anti-eIF3b and anti-eIF3f CoIP assays. (A) Anti-eIF3b and (B) anti-eIF3f co-immunoprecipitation experiments were performed with WCE of HeLa cells 3 days after transfection with non-targeting siRNA. Input (IN), eluate (E) and supernatant (SUP) fractions were subjected to Western blotting with antibodies indicated on both sides; in (A) 8% of IN and SUP and 25% of E, and in (B) 5% of IN and SUP and 20% of E were loaded. For the negative control (neg. ctrl.) the beads without antibodies were used. Octameric eIF3 subunits are arranged at the left-hand side and the non-octameric subunits are shown at the right-hand side. The YLC subunits are highlighted in bold. In (B) the signal of our anti-eIF3e and anti-eIF3g antibodies could not be clearly visualized because of the heavy chain of eIF3f antibodies of the rabbit origin migrating at the same size (n.d. = not determined). The band seen in the E lane with the eIF5 strip is a routinely observed cross-reaction. 
